Sound Pharmaceuticals Receives Award for Drug Used to Treat Hearing Loss in Cystic Fibrosis Patients

Sound Pharmaceuticals announced that the company has been awarded up to $1.6 million for their development of a drug used to treat ototoxicity in patients with cystic fibrosis.